Robert E. Ivy serves as Executive at SONUS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Robert E. Ivy has executed 6 insider transactions totaling $162.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 18, 2007 involved exercising options for 10,000 shares valued at $6.3K.
Robert E. Ivy currently holds 11,700 shares of SONUS PHARMACEUTICALS INC (SNUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert E. Ivy has been a net seller of SNUS stock. They have purchased $0 and sold $162.2K worth of shares.
Robert E. Ivy's most recent insider trade was on May 18, 2007, when they sold 10,000 shares at $0.63 per share.
Get notified when new Form 4 filings are submitted
| $5.46 |
| Discretionary |
| May 17, 2007 | SNUS | $6.3K | Option Exercise | 10,000 | $0.63 | Discretionary |
| May 17, 2007 | SNUS | $53.6K | Sale | 10,000 | $5.36 | Discretionary |
| May 16, 2007 | SNUS | $54.0K | Sale | 10,000 | $5.40 | Discretionary |
| May 16, 2007 | SNUS | $6.3K | Option Exercise | 10,000 | $0.63 | Discretionary |